165 related articles for article (PubMed ID: 12650488)
1. Pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 in rats.
Schywalsky M; Ihmsen H; Tzabazis A; Fechner J; Burak E; Vornov J; Schwilden H
Eur J Anaesthesiol; 2003 Mar; 20(3):182-90. PubMed ID: 12650488
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and clinical pharmacodynamics of the new propofol prodrug GPI 15715 in volunteers.
Fechner J; Ihmsen H; Hatterscheid D; Schiessl C; Vornov JJ; Burak E; Schwilden H; Schüttler J
Anesthesiology; 2003 Aug; 99(2):303-13. PubMed ID: 12883403
[TBL] [Abstract][Full Text] [Related]
3. Comparative pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 and propofol emulsion.
Fechner J; Ihmsen H; Hatterscheid D; Jeleazcov C; Schiessl C; Vornov JJ; Schwilden H; Schüttler J
Anesthesiology; 2004 Sep; 101(3):626-39. PubMed ID: 15329587
[TBL] [Abstract][Full Text] [Related]
4. Propofol in rats: testing for nonlinear pharmacokinetics and modelling acute tolerance to EEG effects.
Ihmsen H; Tzabazis A; Schywalsky M; Schwilden H
Eur J Anaesthesiol; 2002 Mar; 19(3):177-88. PubMed ID: 12071237
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of GPI 15715 or fospropofol (Aquavan injection) - a water-soluble propofol prodrug.
Fechner J; Schwilden H; Schüttler J
Handb Exp Pharmacol; 2008; (182):253-66. PubMed ID: 18175095
[TBL] [Abstract][Full Text] [Related]
6. Influence of different fat emulsion-based intravenous formulations on the pharmacokinetics and pharmacodynamics of propofol.
Cox EH; Knibbe CA; Koster VS; Langemeijer MW; Tukker EE; Lange R; Kuks PF; Langemeijer HJ; Lie-A-Huen L; Danhof M
Pharm Res; 1998 Mar; 15(3):442-8. PubMed ID: 9563075
[TBL] [Abstract][Full Text] [Related]
7. AQUAVAN injection, a water-soluble prodrug of propofol, as a bolus injection: a phase I dose-escalation comparison with DIPRIVAN (part 2): pharmacodynamics and safety.
Struys MM; Vanluchene AL; Gibiansky E; Gibiansky L; Vornov J; Mortier EP; Van Bortel L
Anesthesiology; 2005 Oct; 103(4):730-43. PubMed ID: 16192765
[TBL] [Abstract][Full Text] [Related]
8. Physicochemical properties, pharmacokinetics, and pharmacodynamics of a reformulated microemulsion propofol in rats.
Lee EH; Lee SH; Park DY; Ki KH; Lee EK; Lee DH; Noh GJ
Anesthesiology; 2008 Sep; 109(3):436-47. PubMed ID: 18719441
[TBL] [Abstract][Full Text] [Related]
9. AQUAVAN injection, a water-soluble prodrug of propofol, as a bolus injection: a phase I dose-escalation comparison with DIPRIVAN (part 1): pharmacokinetics.
Gibiansky E; Struys MM; Gibiansky L; Vanluchene AL; Vornov J; Mortier EP; Burak E; Van Bortel L
Anesthesiology; 2005 Oct; 103(4):718-29. PubMed ID: 16192764
[TBL] [Abstract][Full Text] [Related]
10. Influence of hemorrhagic shock followed by crystalloid resuscitation on propofol: a pharmacokinetic and pharmacodynamic analysis.
Johnson KB; Egan TD; Kern SE; McJames SW; Cluff ML; Pace NL
Anesthesiology; 2004 Sep; 101(3):647-59. PubMed ID: 15329589
[TBL] [Abstract][Full Text] [Related]
11. Concentration-EEG effect relationship of propofol in rats.
Dutta S; Matsumoto Y; Gothgen NU; Ebling WF
J Pharm Sci; 1997 Jan; 86(1):37-43. PubMed ID: 9002457
[TBL] [Abstract][Full Text] [Related]
12. Comparative canine pharmacokinetics-pharmacodynamics of fospropofol disodium injection, propofol emulsion, and cyclodextrin-enabled propofol solution following bolus parenteral administration.
McIntosh MP; Rajewski RA
J Pharm Sci; 2012 Sep; 101(9):3547-52. PubMed ID: 22581759
[TBL] [Abstract][Full Text] [Related]
13. An improved design of water-soluble propofol prodrugs characterized by rapid onset of action.
Lang BC; Yang J; Wang Y; Luo Y; Kang Y; Liu J; Zhang WS
Anesth Analg; 2014 Apr; 118(4):745-54. PubMed ID: 24651228
[TBL] [Abstract][Full Text] [Related]
14. Altered dose-to-effect of propofol due to pharmacokinetics in rats with experimental diabetes mellitus.
Leal N; Calvo R; Agrad FZ; Lukas JC; de la Fuente L; Suarez E
J Pharm Pharmacol; 2005 Mar; 57(3):317-25. PubMed ID: 15807987
[TBL] [Abstract][Full Text] [Related]
15. Propofol phosphate, a water-soluble propofol prodrug: in vivo evaluation.
Banaszczyk MG; Carlo AT; Millan V; Lindsey A; Moss R; Carlo DJ; Hendler SS
Anesth Analg; 2002 Nov; 95(5):1285-92, table of contents. PubMed ID: 12401612
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacodynamics of two different propofol formulations].
Ihmsen H; Jeleazcov C; Schüttler J; Schwilden H; Bremer F
Anaesthesist; 2006 Jun; 55(6):635-42. PubMed ID: 16479409
[TBL] [Abstract][Full Text] [Related]
17. The influence of age on propofol pharmacodynamics.
Schnider TW; Minto CF; Shafer SL; Gambus PL; Andresen C; Goodale DB; Youngs EJ
Anesthesiology; 1999 Jun; 90(6):1502-16. PubMed ID: 10360845
[TBL] [Abstract][Full Text] [Related]
18. Targeting effect compartment or central compartment concentration of propofol: what predicts loss of consciousness?
Wakeling HG; Zimmerman JB; Howell S; Glass PS
Anesthesiology; 1999 Jan; 90(1):92-7. PubMed ID: 9915317
[TBL] [Abstract][Full Text] [Related]
19. [Analgo-sedation in intensive care: a quantitative, EEG-based trial with propofol 1% and 2%].
Albrecht S; Ihmsen H; Suchodolski K; Frenkel C; Schüttler J
Anaesthesist; 1999 Nov; 48(11):794-801. PubMed ID: 10631438
[TBL] [Abstract][Full Text] [Related]
20. Influence of administration rate on propofol plasma-effect site equilibration.
Struys MM; Coppens MJ; De Neve N; Mortier EP; Doufas AG; Van Bocxlaer JF; Shafer SL
Anesthesiology; 2007 Sep; 107(3):386-96. PubMed ID: 17721240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
